News for 'Equity Labs'

Accel and Google's AI Fund Invest in Five Promising AI Startups

Accel and Google's AI Fund Invest in Five Promising AI Startups

Rediff.com16 Mar 2026

Accel and Google's AI Futures Fund have announced the five startups selected for the 2026 Atoms AI Cohort, focusing on enterprise, voice, and industrial AI solutions, with each startup receiving significant investment and resources.

Gulf War: US, Israel Didn't Expect This To Happen

Gulf War: US, Israel Didn't Expect This To Happen

Rediff.com27 Mar 2026

The United States, which entered this war in expectation of a short, sharp win along the Venezuela model, is now preparing for deeper involvement in a conflict it does not fully control, without the allies it typically relies on, against an adversary that is not behaving as expected, in a global environment that is already absorbing economic shock. Prem Panicker continues his must read daily blog on the Gulf War.

UPI payments app PhonePe's $1.5 billion IPO to see Walmart cut stake

UPI payments app PhonePe's $1.5 billion IPO to see Walmart cut stake

Rediff.com23 Jan 2026

As India's biggest Unified Payments Interface (UPI) app PhonePe prepares to list, the updated draft red herring prospectus (DRHP) shows the impact of regulations on the business, and concentration of payments-linked revenue even as UPI lacks MDR (merchant discount rate).

Pine Labs CEO Amrish Rau may net Rs 1,000 crore as firm files for IPO

Pine Labs CEO Amrish Rau may net Rs 1,000 crore as firm files for IPO

Rediff.com28 Jun 2025

As fintech major Pine Labs gears up for its initial public offering (IPO), its Draft Red Herring Prospectus has highlighted its top executives' pay and stock options, including those of Chief Executive Officer (CEO) Amrish Rau. Rau's net worth is estimated at Rs 850 crore-1,000 crore following the IPO.

Hungry IPOs Carve A Heft Slice Of Mutual Funds

Hungry IPOs Carve A Heft Slice Of Mutual Funds

Rediff.com22 Dec 2025

In November, six primary market issuances accounted for more than 13,000 crore of net equity investments by MFs.

How This IITian Is Solving India's Clean Air Crisis

How This IITian Is Solving India's Clean Air Crisis

Rediff.com12 Feb 2026

Ravi Kaushik has sold 70,000 units of air filters through his start-up Airth and aims to sell 10 lakh units in the next five years.

The Worry Behind Sam Altman's Rs 4.6-Crore Job Offer

The Worry Behind Sam Altman's Rs 4.6-Crore Job Offer

Rediff.com30 Dec 2025

By publicly attaching such a large sum to this job, OpenAI is telling the world that fears of rogue-AI has entered the boardroom

IPO Wave Hits 3 Decade Peak With 200 Filings

IPO Wave Hits 3 Decade Peak With 200 Filings

Rediff.com13 Oct 2025

This marks the strongest DRHP filing tally since 1996, when 428 firms sought to enter India's equity markets.

600 Crore IPO Fees Light Up Diwali For I-Bankers

600 Crore IPO Fees Light Up Diwali For I-Bankers

Rediff.com24 Oct 2025

With several $500 million-plus deals in the pipeline -- including ICICI Prudential AMC, Lenskart, PhonePe, Groww, PhysicsWallah, Meesho, Pine Labs, and Zepto -- investment bankers look poised for another year of hefty bonuses in 2025.

IPO Secondary Sales Soar Toward Rs 1 Trn

IPO Secondary Sales Soar Toward Rs 1 Trn

Rediff.com20 Nov 2025

Market experts say India's IPO ecosystem has matured to support both primary and secondary issuance, rendering the mix less consequential.

Andhra To Build India's First Giga-Scale Air Taxi Hub

Andhra To Build India's First Giga-Scale Air Taxi Hub

Rediff.com19 Nov 2025

The "Sky Factory" will be one of the world's largest for electric vertical take-off and landing (eVTOL), a manufacturing and assembly process to make electric aircraft that can take off, hover, and land vertically. It will put India on the "map of next-generation aviation" and marks one of the most ambitious eVTOL initiatives in the world, said a state government statement.

Smallcaps Face Their Toughest Samvat Yet

Smallcaps Face Their Toughest Samvat Yet

Rediff.com18 Oct 2025

'Defence, capital goods, engineering, capital market-related stocks, autos, and cement sectors are my bullish bets for Samvat 2082.'

IPO Boom Faces Reality Check Amid Market Volatility

IPO Boom Faces Reality Check Amid Market Volatility

Rediff.com28 Oct 2025

More than a third of 83 mainboard IPOs this year ended their debut sessions in the red, with losses of up to 35 per cent.

BFSI Sector Set For Boom With Rs 58K Cr IPOs

BFSI Sector Set For Boom With Rs 58K Cr IPOs

Rediff.com25 Sep 2025

The sector's IPO pipeline is led by Tata Capital's Rs 17,000 crore issue, followed by ICICI Prudential Asset Management at Rs 10,200 crore and Billionbrains Garage Ventures at Rs 6,000 crore.

'From March 2026, India Should Resume Long-Term Uptrend'

'From March 2026, India Should Resume Long-Term Uptrend'

Rediff.com29 Sep 2025

'Indian markets may underperform global peers for the next two quarters.' 'But beyond that, India should catch up and resume its long-term growth path.'

Why The Americans Were Opposed To Agni

Why The Americans Were Opposed To Agni

Rediff.com6 Nov 2025

'The heat shield technology for re-entry vehicles was first mastered in DRDO for the Agni missile.' 'This is why the Americans were so opposed to Agni in the 1980s, unlike other missiles -- it was a re-entry vehicle.'

Pharma stocks slide as US headwinds hurt

Pharma stocks slide as US headwinds hurt

Rediff.com16 Sep 2025

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.

IPO Pipeline Swells with 118 DRHPs

IPO Pipeline Swells with 118 DRHPs

Rediff.com11 Jul 2025

Experts say the robust filing suggests the second half of the year will see large-scale issuances, provided the markets remain supportive.

'Lost 5 Crores In First Start-Up. What To Do?'

'Lost 5 Crores In First Start-Up. What To Do?'

Rediff.com29 May 2025

rediffGURU Dr Ganesh Natarajan offers advice on how to build and scale your first start-up.

Govt unveils Rs 2 trillion dose for jobs, R&D, innovation, growth push

Govt unveils Rs 2 trillion dose for jobs, R&D, innovation, growth push

Rediff.com2 Jul 2025

In a double-dose bid to boost growth and employment prospects, the Union Cabinet on Tuesday approved a Rs 2.07 trillion outlay for a research development and innovation (RDI) Scheme to fund private sector innovations, and an employment-linked incentive (ELI) to create over 35 million new jobs over the next two years.

Despite market volatility, corporate fundraising at record high in FY25

Despite market volatility, corporate fundraising at record high in FY25

Rediff.com28 Mar 2025

Fundraising by Indian companies through equity and debt reached an all-time high in the financial year 2024-25 (FY25), according to data collated by primedatabase.com. Fundraising through debt stood at Rs 11.1 trillion in FY25, including contributions from InvITs (infrastructure investment trusts) and REITs (real estate investment trusts).

2024 an inflection point in race to become unicorn

2024 an inflection point in race to become unicorn

Rediff.com28 Feb 2025

Startups that became unicorns in 2024 took an average of nine years and six months to reach $1 billion valuation, reflecting the impact of a prolonged funding squeeze from PE/VC firms over the past few years.

Margin pressures, growth triggers to weigh on Dr Reddy's

Margin pressures, growth triggers to weigh on Dr Reddy's

Rediff.com21 May 2025

Pharma major Dr Reddy's Laboratories delivered a muted operational performance in the fourth quarter of financial year 2024-25 (Q4FY25), even as revenue growth remained healthy. Lower gross margin performance and muted domestic growth are key concerns. Most brokerages have a "Sell" or "Reduce" rating as there are uncertainties related to the development of a new product portfolio and the launch timelines.

'Can I Retire At 45 With 3L Per Month?'

'Can I Retire At 45 With 3L Per Month?'

Rediff.com14 Jan 2025

Ask rediffGURU and PF expert Milind Vadjikar your insurance, stocks, mutual fund and personal finance-related questions.

Harvard University adds caste as protected category for student workers

Harvard University adds caste as protected category for student workers

Rediff.com3 Dec 2021

The historic addition marks Harvard as the first Ivy League school to have caste equity protection in its non-discrimination clause for unionised student workers.

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Rediff.com26 Jan 2025

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company's Q3 performance and differed on its growth outlook. DRL's Q3 performance was viewed as subdued by some analysts when they adjusted it for one-time grants and incomes that the company received during the quarter.

10 Stocks That Soared While Market Sank

10 Stocks That Soared While Market Sank

Rediff.com24 Mar 2025

The stocks are largely from sectors such as chemicals, finance and cement, which struggled earlier but the worse seems to be behind them.

Adani group to press the pedal on its retail play through super app

Adani group to press the pedal on its retail play through super app

Rediff.com27 Jun 2024

With an existing consumer base of 400 million across airports, electricity and gas distribution businesses, the Adani group is revving up its retail play. It is planning to use the 2.4 billion consumer interactions a year with group companies to push various products and services. The group has already launched the 'Adani One' super app that will eventually sell products across the spectrum, top executives said.

TCS net profit rises 9% to Rs 12,040 crore in Q1

TCS net profit rises 9% to Rs 12,040 crore in Q1

Rediff.com11 Jul 2024

India's largest IT services company Tata Consultancy Services (TCS) on Thursday posted an 8.7 per cent year-on-year rise in its consolidated net profit at Rs 12,040 crore in the first quarter ended June 2024. The net profit for the year-ago period stood at Rs 11,074 crore.

Should you opt to buy stocks of Divis Labs?

Should you opt to buy stocks of Divis Labs?

Rediff.com21 Apr 2023

The stock of Divis Laboratories is up 10 per cent over the last couple of trading sessions on expectations that the worst is behind and the company could see a sequential growth in the March quarter of the 2022-23 financial year (Q4FY23). The stock witnessed the highest downgrades among Nifty50 index stocks with earnings cuts over a third after the Q3FY23 results. The company had posted a 32 per cent drop in revenues over the year ago quarter in Q3FY23 and 8 per cent sequentially, which was sharply lower than Street expectations.

WazirX looks for white knight; users set to lose 43% funds

WazirX looks for white knight; users set to lose 43% funds

Rediff.com3 Sep 2024

Crypto exchange WazirX has said customers affected by the recent cyber attack will not be able to recover their full funds even as the firm looks to restructure. At a virtual press conference, the firm's advisor said at best the company might look to return 55-57 per cent of the money. "This is what can be returned to users with the benefit of this restructuring," said Jason Kardachi, managing director (restructuring), Kroll.

'Noel Tata Should Be Inducted Into Tata Sons Soon'

'Noel Tata Should Be Inducted Into Tata Sons Soon'

Rediff.com12 Oct 2024

'The quality of a leader should be such that even if the leader is not there, the institution carries on.'

iGenetic Diagnostics: The next generation pathology lab

iGenetic Diagnostics: The next generation pathology lab

Rediff.com12 Apr 2017

When Prashanth Reddy's father was in an ICU he could not find a lab that would deliver a blood infection test report in 24 hours. That's where iGenetic Diagnostics, which uses molecular techniques next generation sequencing, came in.

Valuations, access to capital spur fintechs' homecoming

Valuations, access to capital spur fintechs' homecoming

Rediff.com4 Jun 2024

Why are financial-technology (fintech) players moving back to India, or doing the reverse-flipping?

Bucking the trend: Indian startups regain lost funding ground, says report

Bucking the trend: Indian startups regain lost funding ground, says report

Rediff.com21 Jun 2024

Finally, some good news for the Indian startup ecosystem. After four consecutive half-year periods of declining funding since 2022, the first half (H1) of 2024 has shown an upward trend compared to the second half (H2) of 2023. According to the India Tech Semi-Annual Funding Report H1 2024 by Tracxn, Indian technology (tech) startups raised $4.1 billion in H1 2024, marking a 4 per cent increase from $3.96 billion in H2 2023.

Fall 2024 May Not Be A Repeat Of 2018

Fall 2024 May Not Be A Repeat Of 2018

Rediff.com1 Apr 2024

'We expect the bull-market phase to still persist, but now led by large-caps which offer better valuation and benefit from FII inflows.'
'We expect continued pressure on midcaps, but any sharp correction looks unlikely from here on.'

Dalit rights body in US accuses Google of being casteist, a hostile workplace

Dalit rights body in US accuses Google of being casteist, a hostile workplace

Rediff.com2 Jun 2022

A US-based Dalit civil rights organisation on Thursday accused Google of having a casteist and hostile workplace practices.

iLabs invests Rs 42 cr in VSoft

iLabs invests Rs 42 cr in VSoft

Rediff.com11 Jun 2007

iLabs Private equity fund, a $300 million India-centric fund promoted by former COO of Satyam Computer Systems Srini Raju, has invested Rs 42 crore (over $10 million) in VSoft Corp.

Equity fund, media house to buy majority stake in TV9

Equity fund, media house to buy majority stake in TV9

Rediff.com10 Nov 2011

ABCL owns the TV9 media house, which runs satellite television channels in several regional languages, including Telugu. iLabs is promoted by Raju.

Pharma shares boost markets; Dr Reddy's Labs, Lupin lead

Pharma shares boost markets; Dr Reddy's Labs, Lupin lead

Rediff.com6 Aug 2015

Asian markets were trading mixed with the Nikkei gaining after the US dollar strengthened against the yen.